Market Trends of Global Immunoprecipitation Testing Industry
This section covers the major market trends shaping the Immunoprecipitation Testing Market according to our research experts:
Chromatin Immunoprecipitation (ChIP) is Expected to Dominate the Market by Type Over the Forecast Period
Chromatin immunoprecipitation (ChIP) is a type of immunoprecipitation technique used to investigate the regions of the genome associated with target DNA-binding protein, or to identify the specific proteins associated with a specific region of the genome. Chromatin immunoprecipitation is commonly used in epigenetics research.
ChIP is expected to experience significant growth owing to technological advances. For instance, the Chromatrap technology enables data accuracy and delivers quick results without any pipetting risks, allowing researchers to simultaneously analyze multiple antibodies and gene targets.
In the current COVID-19 pandemic, ChIP plays a vital role in determining the protein-DNA interactions, which is very important in understanding the target binding sequences for the SARS-Cov2 Virus. Thus, as the research progresses, the studied segment is expected to witness significant growth during the pandemic.
Additionally, the key players are involved in research activities to develop improved protocols for chromatin immunoprecipitation, which aids in the growth of the studied market. For instance, in the study published in Bio-Protocol in December 2020, titled 'Chromatin Immunoprecipitation (ChIP) to Assess Histone Marks in Auxin-treated Arabidopsis thaliana Inflorescence Tissue' chromatin immunoprecipitation, coupled with quantitative PCR (Chip-qPCR), was used in the identification of binding sites of DNA binding proteins and the detection of histone modification on locus-specific areas of the genome. Hence, the extensive application of ChIP in various genomic studies is a major factor driving the studied segment over the forecast period.
North America Holds the Major Share in Immunoprecipitation Testing Market and is Expected to Dominate the Market Over the Forecast Period
North America holds the major share in the immunoprecipitation testing market owing to the increasing investments and government funding, especially in biotechnology research, and growing awareness regarding personalized medicine. Additionally, growing collaborations and partnerships between organizations and universities and a high concentration of key regional players are expected to drive the studied market in the region. Various government bodies, like NHGRI (National Human Genome Research Institute), have supported the work on sequencing of the human genome and funded the research that involves the study of the genome's structure, function, and role in human health and various disease.
In April 2020, GlaxoSmithKline invested USD 250 million in Vir Biotechnologies, a San Francisco-based clinical-stage immunology company, to support its antibody-drug development program for COVID-19. Similarly, in April 2020, the federal government granted USD 14.5 million to Emergent BioSolutions-a Maryland-based biopharmaceutical company-to working on an antibody-drug trial for COVID-19. However, this pandemic has slowed the discovery and development activities of biological products for other applications, such as oncology and rare diseases, which may somewhat hamper growth.
With the growing number of COVID-19 cases in the region, particularly in the United States, extensive research employs advanced tools such as immunoprecipitation sequencing to study the DNA-protein interactions and genome analysis. Additionally, according to the research article published by the National Institutes of Health (NIH) in June 2020, titled 'Increasing Prevalence of Antinuclear Antibodies in the United States' the prevalence of antinuclear antibodies (ANA), which is the common biomarker of autoimmunity, was significantly increasing in the United States over the years. Thus, given the aforementioned factors, the North American region is expected to witness significant growth over the forecast period.
